We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$61.9B
1-Year Est. Return
29.81%
This Fund
S&P 500
This Quarter
Est. Return
+15.18%
1 Year Est. Return
+29.81%
3 Year Est. Return
+93.17%
5 Year Est. Return
+119.65%
10 Year Est. Return
–
AUM
$46.2B
AUM Growth
+$4.02B
(+9.6%)
Cap. Flow
-$2.06B
Cap. Flow
% of AUM
-4.46%
Top 10 Holdings %
Top 10 Hldgs %
19.65%
Holding
934
New
52
Increased
488
Reduced
320
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$191M |
| 2 |
Microsoft
MSFT
|
+$169M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$162M |
| 4 |
Netflix
NFLX
|
+$126M |
| 5 |
Philip Morris
PM
|
+$87.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$231M |
| 2 |
Banco Bradesco
BBD
|
+$182M |
| 3 |
Amdocs
DOX
|
+$175M |
| 4 |
Oracle
ORCL
|
+$156M |
| 5 |
Chevron
CVX
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.39% |
| 2 | Technology | 14.48% |
| 3 | Consumer Discretionary | 13.41% |
| 4 | Healthcare | 10.59% |
| 5 | Communication Services | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Clorox
CLX
$11.6B
| $10.1M | 0.02% |
63,181
+15,037
| +31% | +$2.33M |
|
502
Stanley Black & Decker
SWK
$14.2B
| $10.1M | 0.02% |
74,044
+22,766
| +44% | +$2.97M |
|
503
TripAdvisor
TRIP
$1.59B
| $10.1M | 0.02% |
195,753
+55,854
| +40% | +$3.06M |
|
|
BSMX
504
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
| $10M | 0.02% |
1,476,237
-250,100
| -14% | -$1.71M |
|
505
ArcelorMittal
MT
$50.4B
| $9.95M | 0.02% |
487,900
| – | – |
|
506
Rockwell Automation
ROK
$51.4B
| $9.9M | 0.02% |
56,433
+5,813
| +11% | +$989K |
|
507
Ulta Beauty
ULTA
$20.4B
| $9.88M | 0.02% |
28,335
+655
| +2% | +$198K |
|
508
Evergy
EVRG
$20.1B
| $9.85M | 0.02% |
169,625
+6,625
| +4% | +$377K |
|
|
BCPC
509
Balchem Corp
BCPC
$5.23B
| $9.84M | 0.02% |
106,070
-114,615
| -52% | -$9.89M |
|
510
Baker Hughes
BKR
$56.8B
| $9.81M | 0.02% |
353,996
+187,128
| +112% | +$4.73M |
|
511
Republic Services
RSG
$66.7B
| $9.78M | 0.02% |
121,595
+24,337
| +25% | +$1.88M |
|
512
Entergy
ETR
$54.1B
| $9.71M | 0.02% |
202,984
+37,974
| +23% | +$1.72M |
|
513
Petrobras
PBR
$121B
| $9.7M | 0.02% |
609,437
-22,422
| -4% | -$356K |
|
514
OGE Energy
OGE
$10.3B
| $9.63M | 0.02% |
223,356
-3,609
| -2% | -$149K |
|
515
Takeda Pharmaceutical
TAK
$55.1B
| $9.56M | 0.02% |
+469,199
| New | +$9.44M |
|
516
Chipotle Mexican Grill
CMG
$40.8B
| $9.51M | 0.02% |
668,700
+172,700
| +35% | +$2M |
|
517
Sabra Healthcare REIT
SBRA
$5.64B
| $9.47M | 0.02% |
485,791
-144,004
| -23% | -$2.73M |
|
518
Brixmor Property Group
BRX
$9.95B
| $9.46M | 0.02% |
514,993
-27,291
| -5% | -$465K |
|
519
Diamondrock Hospitality Co
DRH
$2.63B
| $9.38M | 0.02% |
865,597
-140,306
| -14% | -$1.45M |
|
520
L3Harris
LHX
$55.9B
| $9.37M | 0.02% |
58,682
+15,339
| +35% | +$2.36M |
|
521
Royal Caribbean
RCL
$78.7B
| $9.34M | 0.02% |
81,440
+25,751
| +46% | +$2.93M |
|
522
Cincinnati Financial
CINF
$28.3B
| $9.3M | 0.02% |
108,293
-86,441
| -44% | -$7.13M |
|
523
Northern Trust
NTRS
$22.2B
| $9.26M | 0.02% |
102,440
+30,611
| +43% | +$2.76M |
|
524
Neurocrine Biosciences
NBIX
$17.7B
| $9.25M | 0.02% |
105,015
-5,565
| -5% | -$465K |
|
525
Advanced Micro Devices
AMD
$851B
| $9.22M | 0.02% |
361,155
+131,653
| +57% | +$2.99M |
|
Similar funds
Aberdeen Group's Q1 2019 Portfolio in Review
As of Q1 2019, Aberdeen Group held 934 positions worth $46.2B, up 9.6% from $42.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Aberdeen Group withdrew a net $2.06B in Q1 2019, closing 33 positions and reducing 320 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class A, an estimated $36M position sold in full.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Aberdeen Group opened a new position in Linde worth $203M.
- Aberdeen Group's largest Q1 2019 buy was Linde: 1,152,668 shares worth $203M.
- Aberdeen Group added most to Microsoft in Q1 2019, an estimated $169M increase.
- Aberdeen Group's biggest Q1 2019 reduction was Pfizer, cutting an estimated $231M.
- Aberdeen Group fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $36M.
- Aberdeen Group's ten largest holdings make up 20% of its $46.2B portfolio in Q1 2019.
- Aberdeen Group opened 52 new positions and closed 33 in Q1 2019.
- Aberdeen Group's portfolio value rose 9.6% quarter-over-quarter to $46.2B.
Based on Aberdeen Group's 13F filing for Q1 2019, filed 14 May 2019.